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The four basic helix-loop-helix myogenic transcription factors, myogenin, Myf5,
MRF4, and MyoD are critical for embryonic skeletal muscle development.
Myogenin is necessary for the terminal differentiation of myoblasts into myofibers
during embryogenesis, but little is known about the roles played by myogenin in
adult skeletal muscle function and metabolism. Furthermore, while metabolism is
a well-studied physiological process, how it is regulated at the transcriptional
level remains poorly understood. In this study, my aim was to determine the
function of myogenin in adult skeletal muscle metabolism, exercise capacity, and
regeneration. To investigate this, I utilized a mouse strain harboring the Myogflox
allele and a Cre recombinase transgene, enabling the efficient deletion of
myogenin in the adult mouse. Myogflox/flox mice were stressed physically through
involuntary treadmill running and by breeding them with a strain harboring the
Duchenne’s muscular dystrophy (DMDmdx) allele. Surprisingly, Myog-deleted
animals exhibited an enhanced capacity for exercise, running farther and faster
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than their wild-type counterparts. Increased lactate production and utilization of
glucose as a fuel source indicated that Myog-deleted animals exhibited an
increased glycolytic flux. Hypoglycemic Myog-deleted mice no longer possessed
the ability to outrun their wild-type counterparts, implying the ability of these
animals to further deplete their glucose reserves confers their enhanced exercise
capacity. Moreover, Myog-deleted mice exhibited an enhanced response to
long-term exercise training. The mice developed a greater proportion of type 1
oxidative muscle fibers, and displayed increased levels of succinate
dehydrogenase activity, indicative of increased oxidative metabolism. Mdx:Myogdeleted mice exhibited a similar phenotype, outperforming their mdx
counterparts, although lagging behind wild-type animals. The morphology of
muscle tissue from mdx:Myog-deleted mice appears to mimic that of mdx
animals, indicating that myogenin is dispensable for adult skeletal muscle
regeneration. Through global gene expression profiling and quantitative (q)RTPCR, I identified a unique set of putative myogenin-dependent genes involved in
regulating metabolic processes. These data suggest myogenin’s functions
during adulthood are distinctly different than those during embryogenesis, and
myogenin acts as a high-level transcription factor regulating metabolic activity in
adult skeletal muscle.
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CHAPTER I:
Myogenin regulates adult skeletal muscle metabolism
and exercise capacity
INTRODUCTION:
The myogenic regulatory factors (MRFs), MyoD [1], Myf5 [2], MRF4 [3-5],
and myogenin [6, 7], are basic helix-loop-helix (bHLH) transcription factors best
known for regulating skeletal muscle development during the embryonic stages
of life [8]. While their functions during adult life are less well known, persistent
expression of these factors into adulthood suggests they play a significant role
during this time. During embryonic development, Myf5 and MyoD are required
for the earlier stages of myoblast determination. In the absence of Myf5,
postnatal (P)0 pups exhibit seemingly normal skeletal muscle at birth, but die
soon thereafter due to improper rib development [9, 10]. MyoD-null mice are
viable and display normal skeletal muscle. In the absence of both Myf5 and
MyoD, P0 pups posses no skeletal muscle or skeletal muscle stem cells [11].
Myogenin is required for the latter stages of myoblast differentiation. Myog-null
mice die perinatally due to severe skeletal muscle deficiency [12]. However,
adult myogenin conditional knock-out mice deleted at P1 are viable with normal
muscle, although they have 37% less body mass [13]. This suggests that
myogenin is dispensable for postnatal development and survival, but plays a role
in overall body homeostasis.
Skeletal muscle is composed of a highly complex and organized
arrangement of structures designed for contraction and movement. (Figure 1)
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Figure 1
Components and structural characteristics of skeletal muscle. (A) Illustration of
a whole muscle cross section broken down into myofibers. (B) Illustration of a
myofiber cross section broken down into myofibrils. (C) Structure of a
sarcomere and the organization of its components. (D) Diagram of proteins
comprising the thick and thin filaments of a sarcomere.

From SHERWOOD. Human Physiology, 5E. © 2004 Brooks/Cole, a part of
Cengage Learning, Inc. Reproduced by permission.
www.cengage.com/permissions
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[for review, see 14]. Muscles are composed of numerous muscle fibers. Each
fiber is further broken down to individual myofibrils. Myofibrils contain the
functional contraction unit of skeletal muscle, the sarcomere. Sarcomeres are
composed of thick myosin filaments in between thin actin filaments and are
linked from end to end by the Z line. Myosin filaments contain thick globular
heads with an actin-binding site and a Myosin ATPase site. Actin filaments are
enwrapped by tropomyosin and troponin. Tropomyosin functions to conceal
actin’s myosin binding site. Troponin is composed of three polypeptide units
which bind actin, tropomyosin, and Ca2+. It functions to secure tropomyosin’s
location over actin’s myosin binding site. During contraction, Ca2+ is released
from the sarcoplasmic reticulum surrounding the muscle fibers and binds to
troponin. Troponin then undergoes a conformational change causing
tropomyosin to shift positions and expose actin’s myosin binding site. ATPbound myosin then binds to actin, and through the dephosphorylation of ATP to
ADP, the myosin head shifts toward the center of the sarcomere. This is called
the actomyosin crossbridge, or power stroke. The power stroke brings the actin
filaments closer together causing contraction. Relaxation is then achieved by
the active transport of Ca2+ back in to the sarcoplasmic reticulum via a Ca2+ –
ATPase pump. This ultimately causes tropomyosin to shift back to its resting
position and cover actin’s myosin binding sites. This well-developed
arrangement of factors provides a foundation through which motion and exercise
can be performed.
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All vertebrate organisms posses a wide variety of skeletal muscle fibers
designed to support the skeletal system that are specialized to maintain body
posture as well as perform a myriad of movements and functions [15].
Depending on which myosin heavy chain (myHC) isoform is expressed, they are
categorized as types 1, 2A, and 2B [16]. Expression of a particular MyHC
isoform dictates the contraction speed for a given fiber [17, 18]. Type 1 fibers,
expressing MyHC type 1, contract the slowest while fiber types 2A and 2B
contract more rapidly. The endurance of a fiber is largely dependent on the rate
by which ATP can be supplied by the tissue during contraction to complete the
power stroke cycle [14]. ATP is produced in skeletal muscle via both glycolysis
and the citric acid cycle. Glucose is acquired by the intramuscular conversion of
glycogen to glucose or can be transported into the muscle from the liver via the
blood stream by transporter factors such as Glucose Transporter 4 (Glut4).
Glucose is first metabolized anaerobically via glycolysis in the cytoplasm. This
process quickly produces 2 net ATP molecules and is the primary source for
ATP in the absence of oxygen. Glucose is converted to two pyruvic acid
molecules, which then enter the citric acid cycle to undergo oxidative
phosphorylation in the mitochondria. This is the primary source for ATP in the
presence of oxygen and produces 36 net ATP per glucose molecule.
The rate limiting steps for the production of ATP are regulated by
metabolic enzymes. Oxidative enzymes found in Type 1 and 2A fibers supply a
slow but constant store of ATP by aerobically metabolizing pyruvic acid derived
from glucose furnished by the blood stream. Glycolytic enzymes more prevalent
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in type 2B fibers quickly and anaerobically metabolize glucose derived from
glycogen supplied by the muscle fiber. This mode of ATP production quickly
exhausts glycogen reserves and is only sustainable for short bursts of energy.
Thus, oxidative type 1 and 2A fibers are more resistant to fatigue and are
required for endurance and skeletal support whereas glycolytic type 2B fibers
fatigue more quickly and are utilized for rapid bursts of speed and strength.
Environmental pressures can incite drastic phenotypic alterations in
existing mature adult skeletal muscle fibers [19]. Experimentally induced
modifications in contraction activity are also known to incite fiber type shifts [20,
21]. These conversions demand tremendous alterations in physical activity for
extensive periods of time [22]. As a result, significant modifications in fiber
character are often not observed in mammalian exercise training studies [23].
Thus long term studies are necessary for determining experimental effects on
skeletal muscle function.
Myogenin has previously been implicated in multiple aspects of mature
skeletal muscle function. Denervated adult muscle tissue expresses increased
levels of myogenin [24, 25]. However, Myog-deleted adult mice are known to be
resistant to neurogenic muscle atrophy due to the downregulation of proteolytic
factors [26]. These studies provide a link between myogenin and mature muscle
fiber turnover. Myog mRNA is preferentially expressed in adult slow-twitch (type
1) muscle fibers while MyoD transcripts are of greater abundance in fast-twitch
(type 2) fibers [27]. Furthermore, the overexpression of myogenin in mature
skeletal muscle tissue has been shown to incite shifts in enzymatic activity from
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glycolytic to oxidative metabolism [28]. Thus myogenin makes for a good
candidate gene to study when investigating the regulatory roles of MRF’s in
adult exercise and metabolism.
The recent generation of a mouse strain harboring the Myogflox allele and
a Cre recombinase transgene allow for the study of myogenin in the adult
mouse. In the present study, Myog-deleted adult mice exhibited an enhanced
capacity for exercise in response to physical stress and were able to further
deplete their glucose stores before reaching exhaustion. Furthermore, these
animals displayed an enhanced response to exercise training when given longterm access to running wheels. Global gene expression analysis reveals
alterations in the expression of metabolic enzymes in the absence of myogenin.
Shifts in metabolic enzyme content may be contributing to the conferment of
these observed phenomena.

7

RESULTS:
Tamoxifen injection of adult Myogflox/flox:Cre+ mice results in efficient
deletion of Myog
A mouse strain harboring the Myogflox allele and a Cre recombinase
transgene was recently generated in the Klein laboratory [29]. While efficient
deletion of Myog from the genome of these animals during the embryonic and
perinatal stages of life had already been achieved, this had never been
attempted during adult life. A single injection of tamoxifen at a dose of 10 mg/40
g of body weight was found to result in a greater than 90% deletion of genomic
DNA (Figure 2A). Myog transcript levels were determined to be less than 5% of
their wild-type counterparts (Figure 2B).

Myog-deleted adult mice exhibit an enhanced capacity for exercise and
oxidative metabolism under low-intensity stress conditions
To determine the exercise capacity for Myog-deleted mice under lowintensity stress conditions, adult Myog-deleted mice were run to exhaustion at a
slow, constant speed of 20m/min at 0° incline (Figure 3). These conditions are
designed to assess endurance since they primarily employ the use of type 1
slow twitch muscle fibers and oxidative metabolism.
Wild-type mice (tamoxifen-injected Myogflox/flox) ran on average 4,000
meters before reaching exhaustion whereas their Myog-deleted counterparts ran
almost 10,000 meters (Figure 4), a significant 2.4 fold difference. Remarkably,
some of these animals ran for more than ten hours before reaching exhaustion.

8

Figure 2
Efficient deletion of Myog in the adult mouse. (A) A single tamoxifen injection at
10mg/40g body weight results in >90% deletion of Myog from Myogflox/flox;Cre+
mice (Myog-deleted, n=10; wild-type n=10). Green bar represents Myog-deleted
values. Red bar represents wild-type control values. Error bars represent one
standard deviation (*P<0.05). (B) Myog transcript levels are also reduced by
over 95% in Myogflox/flox;Cre+ mice. Green bar represents Myog-deleted values
(n=3). Red bar represents wild-type control values (n=3). Error bars represent
one standard deviation (*P<0.05).
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B.

10

Figure 3
Representation of low- and high-intensity treadmill exercise regimens. The lowintensity regimen (in blue) maintains a constant speed of 20m/min until
exhaustion, resulting in the mice running the same distance over any given
period of time after the initial warm up period. This regimen is designed to
employ primarily oxidative metabolism. The high-intensity regimen (in red)
entails increasing the speed of the treadmill by 2m/min every 2 minutes until
exhaustion. This results in the mice running ever increasing distances over a
given two minute period as time goes on. This regimen is designed to employ
glycolytic metabolism.
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Figure 4
Enhanced exercise capacity in Myog-deleted mice during the low-intensity
exercise regimen. Myog-deleted mice ran 2.4 fold more than the wild-type
control group under the low-intensity exercise regimen (Myog-deleted, n=4; wildtype n=5). Green bar represents Myog-deleted values. Red bar represents
wild-type control values. Error bars represent one standard deviation (*P<0.05).
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To begin investigating the observed difference in exercise capacity, blood
lactate and glucose levels were recorded at baseline and exhaustion to gain
insight to the metabolic processes at work. Lactate is a product of glycolysis,
and increased lactate at exhaustion is a commonly used indicator of glycolytic
metabolism. In contrast, unchanged lactate levels would be expected during the
use of oxidative metabolism [30]. Under aerobic endurance conditions such as
these, glucose accessed via the blood stream would be the expected fuel source
whereas glucose converted from glycogen in the muscle would be primarily
utilized during anaerobic stress conditions such as high-intensity sprinting.
Baseline blood lactate levels were virtually identical between the wild-type
and Myog-deleted groups and increased only slightly at exhaustion (Figure 5).
These constant blood lactate levels were consistent with the employment of
oxidative metabolism during this aerobic, low-intensity exercise regimen. Blood
glucose levels for both wild-type and Myog-deleted mice were virtually equal at
baseline but were both dramatically decreased at exhaustion (Figure 6).
Decreased blood glucose levels are also consistent with the use of oxidative
metabolism during this assay. Moreover, blood glucose levels of Myog-deleted
mice were less than half that of their wild-type counterparts at exhaustion. The
data implied that Myog-deleted mice were able to further deplete their glucose
stores before reaching exhaustion and utilized this as a source of energy. This
may give Myog-deleted mice a competitive advantage by conferring upon them
an enhanced capacity for exercise.
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Figure 5
Blood lactate levels in Myog-deleted and wild-type mice at baseline and after
running to exhaustion under the low-intensity exercise regimen. At baseline,
blood lactate levels were virtually equal between the Myog-deleted and wild-type
groups at approximately 3 mmol/L (Myog-deleted, n=4; wild-type n=5). At
exhaustion, blood lactate levels for both groups only modestly increased from
baseline and were virtually equal between the Myog-deleted and wild-type
groups at approximately 4.5 mmol/L. Green bars represent Myog-deleted
values. Red bars represent wild-type control values. Error bars represent one
standard deviation.
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Figure 6
Blood glucose levels in Myog-deleted and wild-type mice at baseline and
after running to exhaustion under the low-intensity exercise regimen. At
baseline, blood glucose levels were virtually equal between the Myog-deleted
and wild-type groups at approximately 150 mg/dL (Myog-deleted, n=4; wild-type
n=5). At exhaustion, blood glucose values were significantly reduced for both
groups. However, Myog-deleted values were significantly less than wild-type
control values. Green bars represent Myog-deleted values. Red bars represent
wild-type control values. Error bars represent one standard deviation (*P<0.05).

18

19

To investigate metabolic and physiological changes in the muscle fibers
of Myog-deleted mice, analyses were performed to determine fiber type
proportions, expression levels of succinate dehydrogenase (SDH), transcript
abundance of genes regulating fatty acid metabolism, and metabolic enzyme
activity levels.
Fiber typing analysis indicated there was no difference in the proportions
of type 1 and type 2 muscle fibers between wild-type and Myog-deleted mice
(Figure 7). This was expected as these mice had not been exposed to long-term
training conditions. Transcript levels for Myosins 1, 2A, and 2B were also
determined to be equal between the two groups in the gastrocnemius muscle
(Figure 8). SDH is a component of the mitochondrial electron transport chain,
and its prevalence is an indicator of overall mitochondrial activity and the aerobic
potential of muscle fibers. Assays for SDH revealed equal levels of activity in
both groups (Figure 9). No differences were detected in the transcript levels of a
panel of genes regulating fatty acid metabolism and Glut4 (Figure 10).
Furthermore, assays detecting the enzymatic activities for a panel of both
oxidative and glycolytic enzymes determined there to be no differences between
the wild-type and Myog-deleted groups in either the slow twitch soleus muscle or
the fast twitch extensor digitorum longus muscle (Figure 11). Thus, Myogdeleted adult mice outran their wild-type counterparts under slow, oxidative
conditions but did not display the typical characteristic changes commonly
associated with enhanced aerobic exercise capacity.
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Figure 7
Fiber type proportion in Myog-deleted and wild-type mice run to exhaustion
under the low-intensity regimen. Myog-deleted and wild-type mice did not
exhibit a significant difference in the proportions of Type 1 and Type 2 muscle
fibers in the soleus muscle (Myog-deleted, n=3; wild-type n=3). Green bar
represents Myog-deleted values. Red bar represents wild-type control values.
Error bars represent one standard deviation.
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Figure 8
Transcript expression levels of Myosins Type 1, 2A, and 2B. Myog-deleted and
wild-type mice did not exhibit a significant difference in the expression of these
factors in the Gastrocnemius muscle (Myog-deleted, n=3; wild-type n=3). Green
bars represent Myog-deleted values. Red bars represent wild-type control
values. Error bars represent one standard deviation.
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Figure 9
Succinate dehydrogenase (SDH) activity in Myog-deleted and wild-type mice run
to exhaustion under the low-intensity regimen. Myog-deleted and wild-type mice
did not exhibit a significant difference in SDH activity in the Gastrocnemius
muscle (Myog-deleted, n=3; wild-type n=3). Green bar represents Myog-deleted
values. Red bar represents wild-type control values. Error bars represent one
standard deviation.
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Figure 10
Transcript expression levels of genes regulating fatty acid metabolism. Myogdeleted and wild-type mice did not exhibit a significant difference in the
expression of these factors in the Gastrocnemius muscle (Myog-deleted, n=3;
wild-type n=3). Green bars represent Myog-deleted values. Red bars represent
wild-type control values. Error bars represent one standard deviation. From left
to right: Acc2 - Acetyl-Coenzyme A carboxylase beta, CD36 - Cluster of
Differentiation 36, Cox8b - Cytochrome C oxidase subunit 8b, Cpt-1 - Carnitine
Palmitoyltransferase I, Glut4 - Glucose Transporter Type 4, Ppar-a - Peroxisome
Proliferator-Activated Receptor Alpha, Ppar-g - Peroxisome ProliferatorActivated Receptor Gamma, UCP2 - Mitochondrial Uncoupling Protein 2, UCP3
- Mitochondrial Uncoupling Protein 3.
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Figure 11
Enzymatic activity levels of factors regulating glycolytic and oxidative
metabolism. Myog-deleted and wild-type mice did not exhibit any significant
differences in enzymatic activity for the factors tested in the Soleus or Extensor
Digitorum Longus muscles (Myog-deleted, n=3; wild-type n=3). Green bars
represent Myog-deleted values. Red bars represent wild-type control values.
Error bars represent one standard deviation.
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Myog-deleted adult mice exhibit an enhanced capacity for exercise and
glycolytic metabolism under high-intensity stress conditions
To determine the exercise capacity for Myog-deleted mice under highintensity stress conditions, adult animals were run at consistently increasing
speeds to exhaustion at 10° incline (Figure 2). These conditions are designed to
assess the sprinting aptitude of the mice and employ the use of fast twitch
muscle fibers and glycolytic metabolism.
Myog-deleted mice ran on average 36% more than their wild-type
counterparts 14 days post-deletion (Figure 12). The appearance of the
phenotype at this early time point implied the enhanced exercise capacity was
due to more sudden changes in fiber composition such as alterations in
metabolic enzyme expression levels as opposed to long term modifications such
as shifts in fiber type proportions.
At six months post-deletion, Myog-deleted mice ran 1.6 fold more than
their wild-type counterparts over the course of 12 separate experiments
conducted during consecutive days (Figure 13). This indicated the phenotype
persists over the long term and suggested the difference in exercise capacity
increased over time.
Blood lactate levels increased dramatically in both groups at exhaustion
(Figure 14). Increased blood lactate levels were consistent with the use of
glycolytic metabolism during this high-intensity exercise regimen. Moreover,
Myog-deleted levels were 52% higher than that of their wild-type counterparts at
exhaustion. However, at the wild-type exhaustion point, blood lactate levels of
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Figure 12
Enhanced exercise capacity in Myog-deleted mice during the high-intensity
exercise regimen. Myog-deleted mice ran 36% more than the wild-type control
group under high-intensity exercise conditions at 14 days post-deletion (Myogdeleted, n=24; wild-type n=24). Green bar represents Myog-deleted values.
Red bar represents wild-type control values. Error bars represent one standard
deviation (*P<0.05).

33

34

Figure 13
Enhanced exercise capacity in Myog-deleted mice during the high-intensity
exercise regimen. Myog-deleted mice ran an average of 57% more than the
wild-type control group under high-intensity exercise conditions at 6 months
post-deletion for 12 consecutive days (Myog-deleted, n=8; wild-type n=7).
Green bar (A) and green line (B) represent Myog-deleted values. Red bar (A)
and red line (B) represent wild-type control values. Error bars represent one
standard deviation (*P<0.05).
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Figure 14
Blood lactate levels in Myog-deleted and wild-type mice at baseline and after
running to exhaustion under the high-intensity exercise regimen. Wild-type
blood lactate levels at exhaustion were increased by 168% over the baseline
values. At the wild-type exhaustion time point, there was no significant increase
in the Myog-deleted group. Myog-deleted blood lactate values at exhaustion
had increased by 305% over the baseline values. These levels were also 50%
greater than the wild-type blood lactate values at exhaustion (Myog-deleted,
n=8; wild-type n=7). Green bars represent Myog-deleted values. Red bars
represent wild-type control values. Error bars represent one standard deviation
(*P<0.05).
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Myog-deleted mice were significantly less than that of the wild-type group.
These data suggested that Myog-deleted mice did not build up lactate as quickly
and possessed a higher lactate concentration threshold before reaching
exhaustion. This may be expected as previous studies have shown that lactate
production may actually retard muscle acidosis.
Blood glucose levels at exhaustion remained constant for the wild-type
group but decreased by 33% for Myog-deleted mice (Figure 15). Constant blood
glucose levels in the wild-type group suggested the use of glycolytic metabolism
during this high-intensity exercise regimen. The decrease in blood glucose for
Myog-deleted mice indicated that these animals were able to further tap into
their glycogen reserves and utilize this as a fuel source to power their glycolytic
metabolism. Increased utilization of glucose might be conferring the observed
enhanced exercise capacity.

Hypoglycemic Myog-deleted adult mice no longer exhibit an enhanced
capacity for exercise and glycolytic metabolism under high-intensity
stress conditions
To determine if the ability of Myog-deleted mice to further deplete their
glycogen stores was responsible for the observed enhanced exercise capacity,
mice were fasted to deplete their glycogen reserves and run on a daily basis
until no difference in running capacity was observed between the Myog-deleted
and wild-type groups. Baseline and exhaustion blood lactate and glucose levels
were then recorded. After 96 hours of fasting, Myog-deleted mice reached
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Figure 15
Blood glucose levels in Myog-deleted and wild-type mice at baseline and after
running to exhaustion under the high-intensity exercise regimen. Wild-type
blood glucose levels at exhaustion were unchanged from the baseline values.
Myog-deleted values at that same time point showed a general downward trend,
but the difference was not significant. Myog-deleted blood glucose levels at
exhaustion were significantly reduced from their baseline values (Myog-deleted,
n=8; wild-type n=7). Green bars represent Myog-deleted values. Red bars
represent wild-type control values. Error bars represent one standard deviation
(*P<0.05).
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exhaustion 10% faster than their wild-type counterparts. Thus, they no longer
displayed an enhanced capacity for exercise at this point (Figure 16).
Baseline blood glucose levels of mice fasted for 96 hours were
approximately half those of the same mice under normal dietary conditions,
indicating that their glycogen stores had been depleted (Figure 17). Blood
lactate levels at exhaustion were approximately twice that of baseline for both
wild-type and Myog-deleted mice, but there was no longer a difference between
the two groups (Figure 18). This suggested the glycolytic metabolism of Myogdeleted mice was no longer enhanced under hypoglycemic conditions. Blood
glucose levels at exhaustion were not significantly altered from the fasting
baseline for either group (Figure 17). Furthermore, there was no longer a
difference between the two groups. These data implied that because glucose
levels were already depleted before exhaustion, Myog-deleted mice were no
longer able to further access their glycogen stores as a source of additional
energy and thus ran the same distance as wild-type mice.
After 96 hours of fasting, normal dietary conditions were restored. After
ten days of recovery, by which time glucose levels would be recovered, the
Myog-deleted group again ran significantly more than their wild-type
counterparts showing an enhanced capacity for exercise.

Myog-deleted mice exhibit an enhanced response to exercise training
To determine the ability of Myog-deleted animals to respond to exercise
training, mice were housed in cages with unrestricted access to exercise wheels

42

Figure 16
High intensity running under fasting conditions. After 96 hours of fasting, Myogdeleted mice ran slightly less than their wild-type counterparts before reaching
exhaustion. Ten days after receiving their food back, Myog-deleted mice once
again exhibited an enhanced capacity for exercise, running significant more than
wild-type mice. Green line represents Myog-deleted values. Red line represents
wild-type control values. Blue line represents fold change (Myog-deleted/Wildtype). Error bars represent one standard deviation (*P<0.05).
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Figure 17
Blood glucose levels in Myog-deleted and wild-type mice under fasting
conditions at baseline and after running to exhaustion under the high-intensity
exercise regimen. Myog-deleted and wild-type blood glucose levels under
fasting conditions at baseline were approximately half that of the fed baseline
levels, indicating these animals were hypoglycemic. At exhaustion, there was
no significant decrease in blood glucose for either group, and there was no
difference between the two groups. Green bars represent Myog-deleted values.
Red bars represent wild-type control values. Error bars represent one standard
deviation.
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Figure 18
Blood lactate levels in Myog-deleted and wild-type mice under fasting conditions
at baseline and after running to exhaustion under the high-intensity exercise
regimen. At exhaustion, blood lactate levels in Myog-deleted and wild-type mice
were both approximately twice that of baseline values, but there was no longer a
difference between the two groups. Green bars represent Myog-deleted values.
Red bars represent wild-type control values. Error bars represent one standard
deviation (*P<0.05).
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outfitted with a mechanism allowing for the application of a loaded resistance for
a period of six months and then subjected to the high-intensity exercise regimen.
Adaptation to exercise is a long-term process and is generally accompanied by
fiber type changes, increased mitochondrial content, and an improved capillary
to fiber ratio [31].
Under resistance-free conditions on the running wheels, wild-type and
Myog-deleted mice ran virtually equal distances (Figure 19). When a 1 kg
loaded resistance was added to the wheels, Myog-deleted mice ran on average
32% farther than their wild-type counterparts for 19 consecutive days. While
compelling, this trend toward increased voluntary running was not statistically
significant.
Trained wild-type mice, those housed in exercise cages for the previous
six months, ran 1.8 fold farther to exhaustion under the high-intensity exercise
regimen than untrained mice, while trained Myog-deleted mice ran 2.2 fold
farther to exhaustion than their untrained counterparts (Figure 20). Thus, the
exercise capacity of trained Myog-deleted mice increased by an additional 21%
as compared to wild-type animals. This implied myogenin indirectly regulated the
pathways controlling long-term metabolic and physiological processes in the
muscle fibers.
To investigate the metabolic and physiological changes as a result of
training in the muscle fibers of these animals, histological analyses were
performed to determine fiber type proportions and overall SDH activity. Both
wild-type and Myog-deleted groups displayed increases in type 1 muscle fibers
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Figure 19
Voluntary wheel running under no resistance and 1kg loaded resistance
conditions. Under no resistance conditions at 4 to 5 months post-deletion, wildtype and Myog-deleted mice exhibited no differences in voluntary running over
the course of 18 consecutive days of running. Under a 1kg loaded resistance at
5 to 6 months post-deletion, Myog-deleted mice exhibited a nonstatistical trend
toward increased running as compared to the wild-type group over 18
consecutive days of running. Green bars represent Myog-deleted values
(n=11). Red bars represent wild-type control values (n=11). Error bars
represent one standard deviation (*P<0.05).
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Figure 20
Enhanced response to exercise training in Myog-deleted mice. After 6 months
of exercise training on voluntary running wheels, both wild-type and Myogdeleted mice exhibited increased running capacities under the high-intensity
exercise regimen. When making a comparison between the untrained and
trained values for each genotype, Myog-deleted mice displayed significantly
greater gains in running capacity over the wild-type group (Untrained Myogdeleted, n=8; Trained Myog-deleted, n=11; Untrained wild-type, n=7; Trained
wild-type, n=10). Green bars represent Myog-deleted values (n=11). Red bars
represent wild-type control values (n=11). Error bars represent one standard
deviation (*P<0.05).
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after training (Figure 21), but this gain was greater in the Myog-deleted animals,
causing the difference between the wild-type and Myog-deleted groups after
training to be statistically significant. This shift in fiber type proportions
suggested the loss of myogenin promoted gradual changes in MyHC isoform
expression and fiber contraction speed. Determination of SDH activity revealed
significantly more positive fibers in the gastrocnemius for both the wild-type and
Myog-deleted groups after training (Figure 22). However, this gain was greater
in the Myog-deleted animals, causing the difference between the wild-type and
Myog-deleted groups after training to be statistically significant. Further
increased SDH levels suggested that these fibers possesed an increase in
number and distribution of mitochondria and had greater overall oxidative
potential.

Myogenin may regulate genes controlling metabolic processes
To begin establishing a basis for elucidating the mechanisms driving
enhanced exercise capacity, putative myogenin gene targets were identified in
adult skeletal muscle via global gene expression profiling followed by qRT-PCR.
Hybridization with adult wild-type and Myog-deleted probes identified multiple
genes with altered expression in the absence of myogenin (Table 1). Genes
regulating metabolic processes including 6-phosphofructo-2-kinase/fructose-2,6biphosphatase 3 (Pfkfb3), pyruvate carboxylase (Pc), dihydropyrimidine
dehydrogenase (Dpyd), and 3-hydroxybutyrate
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Figure 21
Increased proportion of type 1 muscle fibers in hindlimb muscle of trained Myogdeleted mice. Untrained wild-type and Myog-deleted mice exhibited no
significant differences in type 1 muscle fibers (dark fibers). After 6 months of
continuous training in voluntary running wheels, trained Myog-deleted mice
displayed significantly more type 1 muscle fibers over the trained wild-type
group. Green bars represent Myog-deleted values (n=3). Red bars represent
wild-type control values (n=3). Error bars represent one standard deviation
(*P<0.05).
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Figure 22
Increased proportion of succinate dehydrogenase (SDH) positive fibers in
hindlimb muscle of trained Myog-deleted mice. Untrained wild-type and Myogdeleted mice exhibited no significant differences in SDH positive muscle fibers.
After 6 months of continuous training in voluntary running wheels, trained Myogdeleted mice displayed significantly more SDH positive muscle fibers over the
trained wild-type group. Green bars represent Myog-deleted values (n=3). Red
bars represent wild-type control values (n=3). Error bars represent one standard
deviation (*P<0.05).
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Table 1
Genes identified to have significantly altered expression in the absence of
myogenin. Global gene expression profiling via microarray analysis identified
numerous genes involved in metabolism and signal transduction (Myog-deleted
n=3, wild-type n=3). Alterations of 1.4 fold or more were considered to be
significant.
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dehydrogenase-type 1 (Bdh1) were shown to be significantly altered in Myogdeleted mice. These changes in gene expression levels were verified by qRTPCR (Figure 23). In the absence of myogenin, this assay confirmed that the
expression levels of multiple genes regulating metabolic processes in glycolysis
were altered. The gene expression profiling analysis will provide a starting point
from which to determine the underlying basis for enhanced exercise capacity in
Myog-deleted mice.
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Figure 23
Transcript expression levels of genes identified to be altered in the absence of
myogenin. qRT-PCR confirms the altered expression of genes in Myog-deleted
mice identified during global gene expression profiling via microarray analysis.
Green bars represent Myog-deleted values (n=3). Red bars represent wild-type
control values (n=3). Error bars represent one standard deviation (*P<0.05;
**P<.01).
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DISCUSSION:
The role of myogenin in regulating embryonic skeletal muscle
differentiation has been thoroughly investigated. The results presented here
identify new functions for myogenin in response to exercise stress and
demonstrate that Myog-deleted adult mice possess an enhanced capacity for
exercise soon after deletion. These mice display increased levels of lactate
build-up at exhaustion and are able to further tap into glycogen reserves for
energy production that wild-type mice are unable to access. The data suggest
that the loss of myogenin abruptly alters metabolic processes in adult mice, thus
conferring their enhanced capacity for exercise. When given access to a means
of training over time, these shifts in metabolic processes translate into the
acceleration of changes in muscle fibers to induce rapid shifts in fiber type and
mitochondrial activity. The results provide evidence indicating that myogenin
regulates metabolic homeostasis during adult life and may negatively regulate
exercise performance. These findings are particularly striking, because
myogenin is known to be vital for muscle growth and development during
embryonic and postnatal life. Furthermore, the results are consistent with
findings in the literature suggesting that the myogenin:MyoD expression ratio
regulates fiber phenotype [27]. MyoD transcripts have been shown to selectively
accumulate in fast twitch muscle fibers. In Myog-deleted mice, this ratio is
presumably tipped in favor of MyoD, suggesting the development of fast-twitch
characteristics in previously slow-twitch fibers.
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The exercise stress experiments and blood tests performed here are the
first to use Myog-deleted mice to identify functions for myogenin in adult
exercise and metabolism. This physiological approach identified a metabolic
regulatory role for myogenin during exercise. Under high-intensity exercise
conditions, Myog-deleted mice exhibited increased lactate levels at exhaustion.
There is much debate regarding lactate production as the cause of muscle
fatigue and acidosis. Long held views state that a virtually instantaneous and
complete ionization of lactic acid is caused by the low pKa of the carboxylic acid
functional group within lactic acid [32-38]. Thus the decrease in pH and
discharge of a (H+) proton from lactic acid to finally create lactate is defined as
lactic acidosis [39]. Compelling evidence to the contrary indicates that metabolic
acidosis is primarily brought about via alternative mechanisms such as ATP
hydrolysis or increases in the glyceraldehyde-3-phosphate dehydrogenase
reaction rate in glycolysis [40-44]. Furthermore, studies strongly suggest that
lactate production and removal from the muscle actually retards acidosis by
consuming H+ protons [45] and concomitantly transporting H+ across the
sarcolemma [30, 46]. Lactate circulating through the blood can also be taken up
and metabolized by other organs such as the kidneys, skeletal and cardiac
muscle, and liver. Thus increased lactate levels may be contributing to the
enhanced exercise capacity of Myog-deleted mice by slowing acidosis and
muscle fatigue. Furthermore, this impediment to acidosis may be enabling
Myog-deleted mice to metabolize and deplete additional glucose stores before
reaching exhaustion significantly later than wild-type animals.
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Myog-deleted mice also ran farther during the low-intensity exercise
regimen and exhibited significantly decreased glucose levels at exhaustion, but
did not display increased lactate levels. One possible explanation for this would
be a difference in the expression levels of glucose transporter proteins, but no
such differences were detected in the global gene expression analysis or
subsequent GLUT4 transcript detection by qRT-PCR. However, the activity and
arrangement of these proteins at the cell membrane have yet to be determined
and could influence the uptake of glucose. Alternatively, increased lactate
production may still be occurring but the mechanisms for clearing lactate from
the blood in Myog-deleted animals may have been able to compensate.
The long-term effects of Myog-deficiency in the adult have yet to be
elucidated, but extensive voluntary training has uncovered a role in adaptation to
continuous exercise. After six months of open access to running wheels, Myogdeleted mice responded to exercise training 21% better than wild-type mice.
The glucose and lactate advantages proposed above may be slowing the onset
of fatigue during exercise, allowing Myog-deleted mice to run farther and for
extended periods of time. Over the course of months, even a mild enhancement
may translate into significant additional gains in exercise capacity. The loss of
myogenin dramatically shifts fiber type proportions from type 2 to type 1 in
response to long-term training. This shift in fiber type proportions suggests that
Myog-deficiency may promote gradual changes in MyHC isoform expression
and fiber contraction speed. Furthermore, significant increases in SDH
abundance far beyond the increases seen in wild-type mice suggest an
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enhancement in oxidative metabolism possibly through increases in
mitochondrial count and distribution.
These results are also consistent with previous data suggesting
alterations in glycolytic metabolism can be uncoupled from changes in MyHC
fiber type [28]. Myog-deleted animals displaying an enhanced exercise capacity
under the high-intensity regimen two weeks post-deletion did not exhibit a shift in
fiber type proportions. Previous enzyme studies utilizing transgenic mice
engineered to overexpress myogenin reported a shift in enzyme activity from
glycolytic to oxidative metabolism, but no differences in fiber type proportions
were observed. While metabolic enzyme activities determined here in wild-type
and Myog-deleted mice did not reveal shifts in activity, the panel tested did not
comprehensively cover the large number of enzymes involved in regulating
metabolism.
Previous studies have shown myogenin regulates distinctly different
pathways during various stages of life. During embryonic development, many
genes encoding structural and contractile components are strongly
downregulated in the absence of myogenin [47], whereas expression levels of
factors regulating cell fusion, signaling, and adhesion are altered in adult skeletal
muscle stem cells (satellite cells) [13]. Global gene expression analysis
performed here in adult skeletal muscle now identifies potential roles for
myogenin in the regulation of metabolic processes. Pc catalyzes the initial
reaction of glycolysis of pyruvate to oxaloacetate, and when the liver detects
excess lactate levels, Pc activity increases [for review, see 48]. Human Pc
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deficiencies often result in increased lactate levels and/or high lactate:pyruvate
ratios [49-51]. Thus, reduced expression of Pc may be contributing to increased
lactate levels at exhaustion in Myog-deleted mice.
PFKFB3 was significantly upregulated in Myog-deleted mice. PFKFB3
encodes PFK2, which has been shown to regulate the activity of PFK1 and
ultimately drive a rate-limiting reaction during glycolysis, the conversion of
fructose-6-phosphate (F6P) to fructose-1,6-bisphosphate (F1,6BP) via PFK-1
[for review, see 52]. It is expressed in skeletal muscle, activated by hypoxic
stimuli, and exhibits an approximately 400:1 kinase:phosphatase ratio to
enhance glycolytic flux [53-55]. Myogenin has been shown to repress genes
regulating glycolysis and upregulate genes involved in oxidative metabolism.
Myogenin is known to activate HDAC4, a repressor of PFK-1 [24]. In the
absence of myogenin, HDAC4 levels may decrease, deregulating PFKFB3 and
increasing glycolytic activity.
The results presented here suggest that reduced myogenin expression
would be advantageous to mice in the wild. Enhanced exercise capacity would
presumably enable these animals to better escape from predators or become
superior hunters. Thus the question remains as to why the expression of
myogenin persists throughout adulthood. There are multiple possible
explanations. Myog-deleted mice derived from laboratory stocks have been
removed from the wild for many generations. They have not been subjected to
natural environmental pressures and selection processes. Thus, it is possible
that Myog-deleted mice do not display the same survival characteristics as mice
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in the wild. Also, the results imply that Myog-deleted mice are able to further
deplete their glucose stores before reaching exhaustion. This may adversely
enable them to easily become hypoglycemic, which can lead to
unconsciousness, neuroglycopenia, and potentially death. In wild-type mice,
myogenin may act to restrain skeletal muscle activity in favor of glucose
conservation. Furthermore, consistent muscle mass is achieved by a balance
between the rates of protein synthesis and degradation. Recent studies
performed in collaboration with the Olson laboratory at The University of Texas
Southwestern Medical Center in Dallas indicate that myogenin is an essential
activator of muscle atrophy. Through its role in the activation of E3 ubiquitin
ligases, myogenin may act to maintain constant muscle mass by promoting
muscle proteolysis.
The mechanism by which myogenin regulates different pathways during
embryogenesis, postnatal development, and adult life have yet to be elucidated.
Previous studies have focused on embryonic and postnatal development, when
skeletal muscle is undergoing dramatic periods of stem cell proliferation and
differentiation. Conversely, adult skeletal muscle is kept under a much less
dynamic state of maintenance. As the requirements necessary to sustain
muscle homeostasis change from one developmental time point to another, so
may the functions of myogenin change to maintain a viable equilibrium. Myogdeleted adult mice displayed an enhanced capacity for exercise under both lowintensity and high-intensity running regimens. Myogenin may be regulating
pathways that maintain adult muscle fiber character. It may act as a master
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sensor of muscle stress to alter fiber metabolic properties in response to
changing environmental conditions.
This research lends itself to a number of possible future directions. At the
transcriptional level, elucidating the mechanisms conferring differential gene
regulation by myogenin in embryonic versus adult skeletal muscle may provide a
basis for establishing how this is achieved in other families of closely related
factors. Furthermore, the unexpected functions for myogenin identified here
may lead to more translational research projects with the ultimate goal of
generating clinical applications. Blocking the expression of myogenin may
provide useful to the sports medicine industry when developing strategies to aid
in muscle repair and regeneration. Moreover, this research questions the role of
myogenin in muscle wasting disorders. The functions for myogenin during
periods of constant muscle regeneration may be best uncovered by
downregulating its expression in mice harboring the Duchenne’s muscular
dystrophy (DMDmdx) allele.
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CHAPTER II:
Myogenin regulates exercise capacity but is dispensable for muscle
regeneration in adult mdx mice
INTRODUCTION:
Muscular Dystrophy is the most prevalent childhood muscle disorder
found in humans, affecting 1 in 3500 newborn males [56]. Duchenne’s muscular
dystrophy (DMD) is a chronic muscle wasting disease leading to progressive
muscle weakness and atrophy. The disease is caused by mutations within the
dystrophin gene, a critical structural component of the muscle cell membrane
[57]. Physiological symptoms of this disorder become apparent within the first
few years of life, and muscle strength quickly deteriorates by puberty and usually
results in early mortality. Common diagnoses and signs of DMD include
increased blood creatine kinase concentration, increased rates of myofiber
regeneration, centrally located myofiber nuclei, mitochondrial swelling, and
ultimately myofiber necrosis [58]. Animal models of DMD include the mdx
mouse, which has been studied extensively to better understand human DMD
[59-65].
DMD is associated with muscle metabolism dysfunction and muscle
weakness. Neuronal nitric oxide synthase (nNOS) is a dystrophin-associated
protein found near the muscle sarcolemma, and its expression is greatly
reduced in mdx mice [66]. Recently, others have shown that the loss of
interaction between nNOS and PFK contributes to glycolytic dysfunction and
increased fatigability [67]. The forced expression of nNOS in mdx mice
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enhances muscle endurance and glycogen metabolism. These experiments
provide important insights into why mdx mice and humans with DMD experience
progressive muscle weakness associated with muscle wasting and atrophy.
Mammalian muscle fibers are broadly divided into several subtypes
based upon their expression of different myosin isoforms: type 1, type 2A, and
type 2B (type 2X in humans) [68]. Types 1 and 2A are primarily oxidative in
nature and confer increased exercise endurance with a high resistance to
muscle fatigue during aerobic exercise. Type 2B fibers are glycolytic in nature
and allow for anaerobic sprinting or short bursts of strength but fatigue more
quickly. Type 1 fibers are commonly referred to as slow twitch whereas type 2
fibers are labeled as fast twitch. Glucose is a major energy source for all muscle
metabolism, but glycolytic fibers are particularly dependent on glucose for
energy production. Glucose stored as glycogen within skeletal muscle fibers is
utilized to quickly meet the demands of high-intensity exercise. Fatty acids and
glucose acquired from the liver via the blood stream provides the major source
of energy that is utilized during low-intensity exercise. Lactate is a by-product of
anaerobic metabolism and its blood concentration rises coincident with an
increase in exercise intensity [69].
The maintenance and regeneration of skeletal muscle are orchestrated by
the four basic helix-loop-helix Myogenic Regulatory Factors (MRFs): MyoD,
Myf5, MRF4, and myogenin. Myogenin is required for embryonic skeletal
muscle development and for achieving normal body size after birth [12, 13, 29].
Myogenin is primarily expressed in slow-twitch/oxidative myofibers and is

72

sufficient to induce a shift from glycolytic to oxidative metabolism when
overexpressed [27, 28]. Recently, myogenin was discovered to transcriptionally
activate the E3 ubiquitin ligases Fbxo32 and Trim63 following muscle
denervation [26]. The loss of myogenin during adult life confers a resistance to
denervation-induced muscle atrophy. Moreover, as described in chapter 1,
myogenin plays a role in regulating metabolism and exercise endurance during
adult life.
In this chapter, I address whether the loss of myogenin in adult mdx mice
alters mdx muscle regeneration and performance. Surprisingly, the absence of
myogenin appeared to have no adverse effects on muscle regeneration.
Moreover, the exercise capacity of mdx:Myog-deleted adult mice was
significantly improved over the mdx control group, nearly to the level of wild-type
mice. This favorable improvement in exercise endurance was associated with
significant changes in nNOS and Fbxo32 expression, implicating a potential
mechanism for the improvement in muscle fatigue resistance. The results
indicate that further investigation into the manipulation of Myog in mammals with
DMD will be a worthy avenue for the development of new treatment options for
this disease.

73

RESULTS:
Myog is not required for survival in adult mdx mice
To determine the role of myogenin in adult skeletal muscle maintenance and
regeneration, Myog conditional knockout mice harboring a tamoxifen-inducible
Cre recombinase transgene [29] were interbred with the DMDmdx mouse strain.
Wild-type (tamoxifen-injected Myogflox/flox) and mdx animals in the same mixed
genetic background were also generated as controls. Cre-expressing adult
animals 8-12 weeks old were then rendered Myog-deficient via a single injection
of tamoxifen. Determination of transcript expression showed that Myog
transcript levels in mdx mice were 5-fold higher than their wild-type counterparts
(Figure 24). Moreover, mdx:Myog–deleted mice expressed equal levels of Myog
transcripts compared to wild-type. This is expected as mdx mice are in a
constant state of regeneration, when myogenin levels are highly upregulated.
Mdx:Myog-deleted mice exhibited seemingly normal behavior and displayed no
overt adverse phenotypic effects. The results indicated that Myog is not
required for survival in adult mdx mice.

Mdx:Myog-deleted mice exhibit an enhanced capacity for exercise over
their mdx counterparts
Based on the results described in chaper 1, I reasoned that that the loss of
myogenin may confer an enhanced capacity for exercise in mdx mice. Mdx,
mdx:Myog-deleted, and wild-type mice were run on a treadmill to exhaustion
under a high-intensity exercise regimen to determine their exercise capacities.
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Figure 24
Reduced abundance of Myog transcripts in tamoxifen-injected mdx:Myogflox/flox;
Cre+ mice. Myog transcript levels in adult mdx mice were increased by 5 fold
over wild-type levels. Myog transcript expression in mdx:Myogflox/flox;Cre+ mice
treated with a single IP injection of tamoxifen at a dose of 10mg/40g body weight
was approximately equal to that of the wild-type control group. Green bar
represents mdx:Myog-deleted values (n=3). Blue bar represents mdx values
(n=3). Red bar represents wild-type control values (n=3). Error bars represent
one standard deviation (*P<0.05).
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Over the course of 3 consecutive days of running, mdx:Myog-deleted mice ran
on average 11% less than the wild-type group, but 37% farther than their mdx
counterparts before reaching exhaustion (Figure 25). The results suggested that
the absence of Myog confered a significant positive effect on exercise
endurance in mdx mice.

The absence of myogenin alters blood metabolite concentrations during
exhaustive exercise
Deletion of Myog enhances exercise endurance and is associated with
alterations in blood metabolite concentrations. To investigate whether these
phenomena also accompanied increased exercise capacity in mdx:Myogdeleted mice, their metabolic profiles were determined. Pre-exercise blood
glucose concentrations were approximately equal between wild-type, mdx, and
mdx:Myog-deleted groups. Moreover, these concentrations were virtually
unchanged at exhaustion when compared to pre-exercise concentrations, and
when compared between groups (Figure 26). These constant blood glucose
levels indicate the use of glycolytic metabolism during this high-intensity
exercise.
Lactate is a product of glycolysis, and increased blood lactate at
exhaustion is a commonly used indicator of glycolytic metabolism. Virtually
unchanged lactate levels would be expected during the use of oxidative
metabolism. Blood lactate levels at exhaustion were significantly increased for
all three test groups. However, the concentration of blood lactate in mdx:Myog-
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Figure 25
Enhanced exercise capacity in mdx:Myog-deleted mice during the high-intensity
exercise regimen. mdx:Myog-deleted mice ran on average over the course of 3
consecutive days of running 37% more than the mdx control group and 11% less
than the wild-type mice under high-intensity exercise conditions (mdx:Myogdeleted, n=14; mdx, n=14; wild-type n=14). Green bar represents mdx:Myogdeleted values. Blue bar represents mdx values. Red bar represents wild-type
control values. Error bars represent one standard deviation (*P<0.05).
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Figure 26
Blood glucose levels in mdx, mdx:Myog-deleted, and wild-type mice after
running to exhaustion under high-intensity exercise conditions. Baseline blood
glucose levels were virtually equal for all three test groups at between 158 to
177 mg/dL (Myog-deleted, n=14; wild-type n=14). At exhaustion, blood glucose
values remained virtually unchanged for all groups. Green bars represent
mdx:Myog-deleted values. Blue bars represent mdx values. Red bars represent
wild-type control values. Error bars represent one standard deviation.
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deleted mice was 14% greater than wild-type and 51% greater than mdx animals
(Figure 27). The results suggested that mdx:Myog-deleted mice possessed a
higher lactate concentration threshold before reaching exhaustion.

Myog is not required for muscle regeneration in the adult mouse
Histological analyses revealed the muscle morphology of mdx:Myog-deleted
mice to be similar if not identical to that of mdx mice. Conventional signs of
muscle regeneration were observed in both groups including the presence of
myofibers of widely varying sizes containing centrally located nuclei (Figure
28A). Van Gieson staining for collagen and elastin also revealed similar
patterns of mild fibrosis in mdx and mdx:Myog-deleted mice (Figure 28B). To
determine the impact of the absence of myogenin on the dystrophin-glycoprotein
complex, blood CK activity was determined. Both mdx and mdx:Myog-deleted
mice show dramatically elevated CK levels compared to wild-type control mice
(Figure 29). These results demonstrated that myogenin’s absence in adult mdx
mice did not reverse the pathological effects of muscular dystrophy in skeletal
muscle. Furthermore, the absence of Myog in mdx mice did not exacerbate
muscle dystrophy, indicating that Myog is dispensible for muscle regeneration.

Myofiber characteristics of mdx:Myog-deleted adult mice
The deletion of Myog in mdx mice might alter muscle properties such as fiber
type proportion and glycogen content. qRT-PCR was performed to determine
transcript levels for myosin type 1, type 2A, and type 2B isoforms in the
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Figure 27
Increased blood lactate levels in mdx, mdx:Myog-deleted, and wild-type mice
after running to exhaustion under high-intensity exercise conditions. Blood
lactate levels were significantly elevated for all three test groups at exhaustion.
Wild-type and mdx:Mog-deleted values were significantly greater than those of
the mdx group. Green bar represents mdx:Myog-deleted values (n=12). Blue
bar represents mdx values (n=11). Red bar represents wild-type control values
(n=10). Error bars represent one standard deviation (*P<0.05).
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Figure 28
Histological evaluation of mdx, mdx:Myog-deleted, and wild-type hindlimb
muscle. (A) Hematoxylin and eosin stained mdx and mdx:Myog-deleted muscle
sections both displayed classic characteristics of regeneration including wide
variations in fiber caliber and centrally located nuclei that were not observed in
wild-type samples. (B) Staining for collagen and elastin reveals similar levels of
fibrosis in mdx and mdx:Myog-deleted muscle sections that are not observed in
wild-type samples.
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Figure 29
Increased concentration of blood creatine kinase in mdx and mdx:Myog-deleted
mice. Blood creatine kinase levels were significantly elevated for both mdx and
mdx:Myog-deleted mice compared to the wild-type control group, but there was
no significant difference between the mdx and mdx:Myog-deleted groups. Green
bar represents mdx:Myog-deleted values (n=9). Blue bar represents mdx values
(n=10). Red bar represents wild-type control values (n=6). Error bars represent
one standard deviation (*P<0.05).
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gastrocnemius muscles of mdx, mdx:Myog-deleted, and wild-type control mice.
No significant changes in the expression of these transcripts between mdx and
mdx:Myog-deleted mice were detected (Figure 30).
Glycogen staining of muscle sections revealed a dramatic increase in
glycogen content in mdx:Myog-deleted muscle compared to mdx and wild-type
muscle samples (Figure 31A). However, attempts to quantify the data using
whole muscle homogenates with a glycogen biochemical assay were unable to
confirm the significance of this observation (Figure 31B). The results indicated
that the deletion of Myog from mdx mice did not alter myosin isoform distribution
but may have increased glycogen abundance.

Expression levels of genes regulating muscle fatigue, metabolism, and
proteolysis are altered in mdx:Myog-deleted adult mice
To begin elucidating the mechanisms driving the observed enhanced exercise
capacity of mdx:Myog-deleted mice over their mdx counterparts, putative
myogenin target genes were identified in adult skeletal muscle. Transcript levels
of genes regulating muscle development, metabolic processes and muscle
proteolysis such as nNOS, Pfk, Hdac4, Trim63, Fbxo32, glycogen synthase, and
muscle glycogen phosphorylase were measured. Of these genes, the
expression of nNOS and Fbxo32 were significantly altered in the absence of
myogenin (Figure 32). These changes in expression may contribute to the
observed enhanced exercise capacity in mdx:Myog-deleted mice over the mdx
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Figure 30
Myosin expression levels in mdx, mdx:Myog-deleted, and wild-type hindlimb
muscle. No significant changes in transcript expression values, as assessed by
qRT-PCR, for myosins type 1, 2A, and 2B were observed between the mdx and
mdx:Myog-deleted groups. Slight but significant alterations in myosins types 2A
and 2B were detected between wild-type and mdx:Myog-deleted mice. Green
bars represent mdx:Myog-deleted values (n=3). Blue bars represent mdx values
(n=3). Red bars represent wild-type control values (n=3). Error bars represent
standard error of the mean.
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Figure 31
Glycogen content in wild-type and Myog-deleted hindlimb muscle. (A) PAS
staining for glycogen in the gastrocnemius reveals similar levels of glycogen in
mdx and wild-type samples, but suggests the mdx:Myog-deleted sections may
harbor increased glycogen content. (B) Biochemical data suggests a
nonstatistical trend toward increased glycogen content in the soleus and EDL
muscles of mdx:Myog-deleted mice. Green bars represent mdx:Myog-deleted
values (n=3). Blue bars represent mdx values (n=3). Red bars represent wildtype control values (n=3). Error bars represent standard error of the mean
(*P<0.05).
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Figure 32
Altered expression of nNOS and Fbxo32 in mdx, mdx:Myog-deleted, and wildtype hindlimb muscle. As verified by qRT-PCR, transcript levels of nNOS were
dramatically reduced in mdx mice. Expression of nNOS was increased by 2.2
fold in mdx:Myog-deleted mice over their mdx counterparts. Fbxo32 expression
was determined to be significantly increased in mdx mice over the mdx:Myogdeleted group and showed a trend toward increased expression over wild-type
mice. Green bars represent mdx:Myog-deleted values (n=3). Blue bars
represent mdx values (n=3). Red bars represent wild-type control values (n=3).
Error bars represent one standard deviation (*P<0.05).

94

95

group and could provide insight into the mechanisms by which myogenin exerts
its effects.
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DISCUSSION:
Myogenin is an essential transcription factor involved in the development
of muscle fibers during embryogenesis [12, 29, 70]. Myogenin’s role in the
maintenance and regeneration of adult skeletal muscle has been long
speculated but not tested in model systems where muscle regeneration is
genetically compromised. In this study, essential coding and regulatory regions
of the Myog locus were conditionally deleted from mdx adult mice. Efficient
deletion of Myog was achieved after tamoxifen-induced Cre-mediated
recombination. Mdx:Myog-deleted mice exhibited no remarkable differences in
their behavior or mobility when compared to wild-type controls. These results
are consistent with previous studies indicating that Myog is dispensable during
adult life [13, 29].
Given that Myog is activated upon muscle injury to help facilitate muscle
repair and regeneration, and mdx mice exist in a constant state of muscle
regeneration [71], I expected that Myog transcripts would be upregulated in
muscle from mdx mice. Myog transcript levels were dramatically increased in
mdx mice while mdx:Myog-deleted mice exhibited levels much closer to wildtype controls. As skeletal muscle stem cells are activated to repair and fuse with
existing muscle fibers, myogenin expression increases in the latter stages of
differentiation. These compensatory events in mdx mice result in muscle
hypertrophy characterized by increases in muscle mass, fiber count, centrally
located nuclei, and distribution of the fiber calibers in mdx mice [60, 72, 73]. The
results described in this chapter confirm previously published studies indicating
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that myogenin expression is elevated in mdx mice [74]. The efficient deletion of
Myog and its subsequent downregulation in mdx mice resulted in no noticeable
adverse effects and indicates that Myog is not required for survival or normal
muscle function in these animals.
Since dystrophic muscle exists in a constant state of damage repair [62,
63, 65, 75], I hypothesized that vigorously exercised mdx mice would exhibit a
dramatic reduction in exercise capacity compared to wild-type mice. Under
high-intensity exercise conditions, mdx mice ran 35% less than wild-type
controls. Mdx:Myog-deleted mice ran 36% farther than the mdx control group,
nearly equaling the distances achieved by wild-type control mice. These data
agree with previous findings described in chapter I and indicate that mdx mice,
like wild-type mice, benefit from the loss of myogenin and exhibit similar gains in
exercise capacity following Myog-deletion.
Results described in chapter I indicated that the deletion of Myog
enhanced exercise endurance by altering skeletal muscle metabolism. The
metabolic changes were evidenced by alterations in blood glucose and lactate
concentrations following exercise. While blood glucose was significantly
depleted below wild-type levels in Myog-deleted mice following high-intensity
exercise, mdx:Myog-deleted mice exhibited blood glucose levels equal to that of
the wild-type and mdx control groups. This result is expected as the highintensity exercise regimen is designed to employ the use of glycolytic
metabolism, which primarily utilizes muscle glycogen as a fuel source.
Mdx:Myog-deleted mice often reach exhaustion before metabolizing significant
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amounts of liver glycogen, thus leaving blood glucose concentrations at normal
levels. The lack of observable blood glucose depletion in mdx:Myog-deleted
mice suggests that the inherent muscle weakness of mdx mice limits exercise
endurance, thus preventing their blood glucose levels from dropping below those
of wild-type mice. Blood lactate concentrations were significantly elevated in
mdx:Myog-deleted mice compared to the mdx control group following highintensity exercise. These results suggest that the loss of myogenin in mdx mice
confers an increased lactate threshold before reaching exhaustion.
As discussed in chapter I, lactate production may actually retard muscle
acidosis. The conversion of pyruvate to lactate by lactate dehydrogenase also
generates NAD+. This aids in sustaining the NAD+/NADH cytosolic redox
potential which promotes substrate flux through glycolysis and ultimately
enables the glycolytic production of ATP [30]. Furthermore, this reaction
consumes an additional proton from the cytosol and is thus alkalizing to the
muscles. The discharge of lactate from the muscle is facilitated by
monocarboxylate transporter [32, 76-79], a known symport for proton removal
from muscle fibers. The transport of lactate out of the muscle by this
mechanism is stoichiometrically accompanied by the removal of protons. In fact,
published data suggests the rate of proton removal outpaces the rate of lactate
removal in active muscle [80]. Thus, increased blood lactate levels may
contribute to the observed increase in exercise capacity.
Mdx mice exhibit defects in muscle regeneration due to the absence of
dystrophin at the sarcolemma [81]. These defects in muscle regeneration are
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readily apparent after bouts of intense exercise and generally result in chronic
muscle weakness. As mdx:Myog-deleted mice exhibited enhanced exercise
endurance, I determined whether their muscles displayed signs of improved
muscle function. No remarkable changes were detected in the muscle
pathology of mdx:Myog-deleted mice when compared to the mdx control group.
Characteristic signs of muscle regeneration such as centrally located nuclei and
wide variations in myofiber diameter were observed in both mdx:Myog-deleted
and mdx mice. Mdx muscles are also particularly prone to fibrosis due to the
increased production of connective tissue that is coincident with defective
muscle regeneration and muscle atrophy [58]. No differences were detected in
the abundance of fibrotic tissue from the muscles of mdx:Myog-deleted mice
compared to the mdx control group. Elevated blood CK levels resulting from the
leakage of CK through the damaged sarcolemma are also characteristic of
dystrophic muscle [82]. Dramatically elevated blood CK levels were observed in
both mdx:Myog-deleted mice and the mdx control group when compared to wildtype. Given that CK levels remained elevated in mdx:Myog-deleted mice, the
sarcolemmal defects normally associated with dystrophin deficiency are likely
unrepaired in these animals. Although mdx:Myog-deleted mice display
enhanced exercise endurance, the pathology of these mice resembles that of
the mdx control group.
Surprisingly, mdx mice did not display an increased penetrance of
muscular dystrophy following the deletion of Myog. The mice displayed no overt
adverse phenotypic characteristics with seemingly normal activity levels. This is
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unexpected since mdx:MyoD(-/-) mice are known to exhibit a severe dorsalventral curvature of the spine, become progressively less activity, and incur
premature death [83]. This suggests that the loss of myogenin neither enhances
nor impairs muscle regeneration and is thus dispensable for these processes.
In mammalian muscle, enhanced exercise endurance is typically
associated with increases in type 1 and type 2A muscle fibers as well as
increases in muscle glycogen content [84]. To determine whether a change in
muscle fiber type or glycogen content was conferring the observed enhanced
exercise capacity in mdx:Myog-deleted mice, histological, biochemical, and gene
expression analyses were performed. Selected hindlimb muscles from
mdx:Myog-deleted mice displayed no significant differences in myosin isoform
expression when compared to the mdx control mice. The staining of muscle for
glycogen abundance suggested there was increased glycogen content in
mdx:Myog-deleted samples. Biochemical analyses of whole muscle glycogen
content also revealed a trend toward increased glycogen in mdx:Myog-deleted
muscle. The results indicated that myofibers of mdx:Myog-deleted mice may
contain more glycogen than their mdx counterparts, but display many other
characteristics similar to that of mdx mice.
Dystrophin deficiency confers a complex pathophysiology in mdx mice
due to the secondary loss of other dystrophin-glycoprotein complex factors [67].
In fact, 80-90% of all dystrophin-glycoprotein associated factors are absent in
mdx mice [66, 85]. These proteins are synthesized as normal, but without
dystrophin they are unable to incorporate into the sarcolemma properly and are
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thus targeted for degradation [86]. One of these factors is nNOS. Mice deficient
for nNOS are unable to oppose vasoconstriction resulting in ischemia and
increased fatiguability [87, 88]. Furthermore, nitric oxide has been shown to
regulate neuromuscular transmission [89] as well as enhance mitochondrial
biogenesis [90] and GLUT4 production and transport [91], suggesting that
reduced nitric oxide production could contribute to the early onset of fatigue [92].
Recently, Wehling-Henricks et al. showed that a loss of interaction
between nNOS and PFK contributes to glycolysis defects and increased
fatigability in mdx mice [67]. Given these results, I determined whether nNOS
and PFK expression would be affected by the deletion of myogenin from mdx
mice. The results confirmed a dramatic decrease in nNOS expression in mdx
muscle compared to wild-type and detected a 2.2-fold increase in nNOS
expression in mdx:Myog-deleted muscle compared to mdx samples; PFK
expression remained unchanged. The increase in nNOS expression in
mdx:Myog-deleted mice could contribute to their reduced fatigability and may
help explain their enhanced exercise endurance compared to the mdx control
group.
Recently, Moresi et al. showed that Myog-deleted mice are resistant to
denervation-induced muscle atrophy [26]. Myogenin was found to activate
Trim63 and Fbxo32, E3 ubiquitin ligases involved in muscle proteolysis and
atrophy. Trim63 and Fbxo32 are normally upregulated in various models of
muscle wasting, and a deficiency of these factors protects against muscle
atrophy. The loss of myogenin was associated with preserved muscle mass
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following denervation and diminished expression of Trim63 and Fbxo32. Their
results suggest the involvement of myogenin in a molecular pathway responsible
for muscle wasting disorders and prompted us to determine Trim63 and Fbxo32
expression levels in mdx mice lacking myogenin. Although no changes in
Trim63 expression were observed, a significant reduction in Fbxo32 expression
in mdx:Myog-deleted mice was detected. This result is consistent with the study
described above and suggests that the loss of myogenin may downregulate
Fbxo32 activity. The reduction in Fbxo32 expression may help protect against
the inherent and chronic muscle atrophy found in dystrophic muscle.
In humans, DMD is a chronic muscle disease leading to progressive
muscle weakness and muscle wasting. The mdx mouse model described here
reliably demonstrates that the exercise capacity of mdx mice is considerably less
than that of wild-type control mice. The observed decrease in exercise capacity
of mdx mice is similar to the muscle weakness typically observed in humans with
DMD and is likely caused by similar mechanisms. When Myog was deleted from
mdx mice, significant increases in exercise endurance were observed that are
associated with changes in the expression of nNOS and Fbxo32. While
mdx:Myog-deleted mice exhibited an enhanced capacity for exercise, no
differences were detected in the histopathology of their muscles compared to the
mdx control group. Thus, the loss of myogenin from mdx mice may rescue their
inherent glycolytic dysfunction and muscle weakness, allowing for increased
muscle endurance.
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Currently, there are no effective treatments to stop the progression or
reverse the effects of DMD. Therapies and treatments for this disease, such as
corticosteriods and orthotics, are limited and only serve to delay the onset of
progressive muscle weakness and eventually death. New therapeutic strategies
aim to treat DMD at the molecular level, such as gene replacement therapy and
exon skipping. Our results suggest that reducing Myog expression in mdx mice
could contribute to the development of new therapeutic strategies for human
DMD. Future directions could include the development of an RNAi delivery
system targeting Myog transcripts in adult mdx mice. If similar enhancements in
exercise capacity are observed in those animals, a more translational research
approach may be warranted to apply this strategy to larger animals with the
ultimate goal of developing therapies for humans with DMD.
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APPENDIX:
Elucidating the mechanisms conferring selective target gene activation by
myogenin
INTRODUCTION:
Developmental diversity is regarded, in part, to be the evolutionary result of
individual transcription factor family members taking on specific roles in
regulating selective gene targets [93]. Little is known about how closely related
transcription factors distinguish their respective target genes. Elucidating
mechanisms that confer this selectivity will provide insight into how this is
achieved in transcription factor families composed of closely related members.
As gene duplications are a major feature of the human genome, understanding
the mechanisms by which this functional specialization is obtained is especially
pertinent [94].
As discussed in chapters 1 and 2, the roles of the myogenic regulatory
factors (MRFs), MyoD [1], Myf5 [2], MRF4 [3-5], and myogenin [6, 7], have been
well established in embryonic skeletal muscle development. Of special interest
to this investigation are myogenin and MyoD. The functions of these two factors
during embryogenesis are markedly different, yet they share nearly
indistinguishable basic helix-loop-helix DNA binding sequences and remarkable
homology in other domains [95]. The transcriptional mechanisms enabling
MyoD and myogenin to selectively activate specific sets of target genes are still
largely unknown. MyoD and myogenin both bind to sequence consensus sites
called E-boxes (CANNTG) found in the transcriptional control regions (TCRs) of
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muscle-specific genes. MyoD regulates the initial stages of limb skeletal muscle
development during the early determination of myoblasts, embryonic skeletal
muscle stem cells. The expression of MyoD also persists into the differentiation
stages of myogenesis. Myogenin is upregulated in the latter stages of
myogenesis and is required for the terminal differentiation of myoblasts into
myofibers [96, 97].
Myogenin selectively activates target genes such that MyoD cannot
compensate for the loss of myogenin. Although myogenin and MyoD share
significant sequence homology, in Myog-null myoblasts, MyoD cannot activate
the transcription of many myogenin target genes. Myog-null mice exhibit
skeletal muscle precursor cells expressing MyoD, but possess few or no
functional myofibers and die pernatally due to a severe skeletal muscle
deficiency [12, 70, 98, 99]. Thus myogenin activates its own unique set of target
genes. Discerning how this mode of selectivity is achieved is an important step
in obtaining a comprehensive understanding of the myogenic regulatory
network. Extensive knowledge of the myogenic regulatory network makes the
skeletal muscle gene regulatory system a valuable model for determining how
closely related transcription factors regulate selective clusters of target genes
[100, 101].
Both chromatin modifications and cofactors have been shown to play
important roles in regulating skeletal muscle-specific gene activation. For
example, histones H3 and H4 are acetylated following the recruitment of the
histone acetyltransferase p300 to the promoter of muscle-specific genes [96].
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Cofactors such as E12/47 and MEF2C are critical for synergistically activating
muscle-specific genes [102-104], and E-boxes and MEF2 binding sites are often
found in very close proximity [105]. Elements such as these may play a role in
conferring target gene selectivity.
Recent investigations have attempted to explain how myogenin and MyoD
may utilize their functional differences to work in concert during the activation of
late-expressing genes in myogenesis [96, 106, 107]. MyoD is known to bind at
the TCR’s of muscle-specific genes and activate the expression of earlyexpressing factors [108-110]. It’s expression also persists into the differentiation
stages of myogenesis where it binds to and initiates chromatin remodeling in
late-expressing genes through the recruitment of factors such as HAT3/4 and
BRG1 , although it is thought to be insufficient for the activation of these factors
[106, 108]. Myogenin is highly upregulated in the latter differentiation phases of
myogenesis and activates the transcription of late-expressing genes. However,
myogenin appears to be incapable of binding to the TCRs of many musclespecific genes in the absence of MyoD. Ohkawa et al speculate that myogenin
replaces MyoD at the E-box to initiate transcription in late-expressing genes
whereas others hypothesize MyoD is required to first bind and initiate the
remodeling of chromatin in order to allow the concomitant binding of myogenin
at the TCR and activate transcription [106, 108-110]. These models discerning
MyoD- from myogenin-mediated gene activation fail to address the mechanisms
by which binding to gene regulatory regions early in myogenesis differs from
binding to regulatory regions late in myogenesis.
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Myogenin and MyoD share significant sequence similarities, yet they
function in different capacities. The mechanisms conferring the specific
activation of early- or late- expressing genes in myogenesis have yet to be
identified. I hypothesize that myogenin acts as a selective activator of
transcription through a regulatory network composed of both chromatin
modifications and cofactors that are distinct from those employed by MyoD,
thereby allowing it to activate specific sets of target genes.
In this appendix, I describe the creation of a Tet-On Myog-inducible cell
culture system. This system allows for the activation and deactivation of Myog
in myoblasts under either proliferating or differentiating conditions. Once
established, these cells will be used as a tool to elucidate the mechanisms
responsible for conferring target gene specificity.
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Results
Myog-null myoblasts were isolated and characterized from the tongue
tissue of Myog-/- E15.5 mouse embryos. Embryos were isolated and tongue
tissue was dissected. Tissue samples were then finely minced, treated with
collagenase, and grown in culture. Cells from separate embryos were pooled
after genotyping confirmed the absence of myogenin. Pre-platings were
performed to remove fibroblasts and other contaminating cells. Genotyping
performed after pooling and pre-plating indicated both the absence of the wild
type allele and the presence of a neomycin cassette (as a result of generating
the knockout mouse) (Figure 33). Immunofluorescence using primary antibodies
against markers for skeletal muscle stem cells indicated that the cells expressed
these markers (Figure 34). When placed in differentiation media for 24 hours,
cells began to elongate and fuse together, classic signs of differentiation (Figure
35). This analysis verified that the isolated cells were embryonic skeletal muscle
stem cells.
The Retro-X Tet-On Advanced Inducible Expression System from
Clontech (www.clontech.com) was employed to generate Myog-null myoblasts
stably infected with an inducible form of myogenin. The system requires the
generation of a double-stable cell line. First, the cells must be stably infected
with the vector coding for the tetracycline-controlled transactivator (pRetroX-TetOn Advanced). The cells are then infected with the vector containing the gene
of interest (pRetroX-Tight-Pur).
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Figure 33
Genotype verification of isolated Myog-null cells. Putative myoblasts isolated
from Myog-null E15.5 tongue tissue exhibit both the absence of the wild type
allele (A) and the presence of a neomycin cassette (B) (as a result of generating
the knockout mouse).
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Figure 34
Differentiation of putative myoblasts into myotubes. Putative myoblasts isolated
from Myog-null E15.5 tongue tissue proliferate continually in high-concentration
fetal bovine serum (FBS) media. When switched to low-concentration horse
serum media for 24 hours, cells cease proliferation and begin to differentiate,
elongating and fusing together to form myotubes.
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Figure 35
Verification of expression of skeletal muscle stem cell markers.
Immunofluorescence using primary antibodies against markers for skeletal
muscle stem cells (MyoD, C-met, Pax3, M-cadherin, and Desmin) indicated the
isolated cells do express these markers.
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The pRetroX-Tet-On Advanced vector utilizes a neomycin cassette so
that stably infected cells can be selected for using G418 in drug selection.
Because Myog-null myoblasts already expressed a neomycin cassette as a
result of generating the null line, the vector was engineered with an alternate
method for drug selection. The neomycin cassette was excised and a blasticidin
cassette from another vector was subcloned in its place (Figure 36).
Myog cDNA followed by an IRES-GFP cassette was subcloned into the
pRetroX-Tight-Pur vector (Figure 37). This was achieved by generating a MyogGFP topovector, removing the Myog-GFP sequence, and ligating into the linear
pRetroX-Tight-Pur vector to create the final pRetroX-Tight-Pur-Myog-GFP
vector. This vector was later sequenced to verify the orientation and the
absence of mutations.
Both vectors described above were transiently transfected into Eco-Pack
293 packaging cells to generate retrovirus stocks. Virus-containing medium was
collected and the viral titer was determined by colony formation.
A death curve for the Myog-null myoblasts with varying concentrations of
blasticidin & puromycin was performed to determine the minimal concentrations
necessary to eradicate all the cells. These concentrations were then used for
drug selection.
A single-stable RetroX-Tet-On Advanced cell line was then generated by
infecting Myog-null myoblasts with the RetroX-Tet-On Advanced vector. The
infection was allowed to proceed for 24 hours. Blasticidin was then added to the
plates and 40 colonies were isolated using cloning discs.
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Figure 36
Verification of replacement of Neomycin cassette for Blasticidin cassette in the
pRetroX-Tet-On Advanced vector. The neomycin cassette was excised and
subcloned in its place was a blasticidin cassette. Restriction digestions indicate
the insertions were of the expected sizes.
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Figure 37
Verification of Myog-GFP cassette insertion into the pRetroX-Tight vector. Myog
cDNA followed by an IRES-GFP cassette was subcloned into the pRetroX-TightPur vector. Restriction digestions indicate the insertions were of the expected
sizes.
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The viability of the RetroX-Tet-On Advanced clones was tested by
infecting them with a luciferase reporter vector that is activated by the
tetracycline-controlled transactivator encoded by the RetroX-Tet-On Advanced
vector. Each clone was then treated with 500 ng/ml of Doxycycline (Dox) and
the fold induction was determined. Clones exhibiting 20- to 50-fold induction
were chosen to generate double-stable lines (Figure 38).
To accomplish this, single-stable Myog-null myoblasts were infected with
the pRetroX-Tight-Pur-Myog-GFP vector to generate double-stable lines. The
infection was allowed to proceed for 24 hours. Puromycin was added to the
plates and colonies were isolated using cloning discs.
Double-stable cell lines were then screened by qRT-PCR for the
presence of Myog transcripts in the presence and absence of Dox at 500 ng/ml.
Multiple lines exhibiting significant induction in the presence of Dox and little to
no induction in the absence of Dox (Figure 39) were frozen in liquid nitrogen.
Cell line 11 was chosen as the primary line for further study.
Since the pRetroX-Tight-Pur vector contained Myog cDNA followed by an
IRES-GFP cassette, induced double-stable Myog-null myoblasts expressed GFP
(Figure 40). Furthermore, double immunostaining showed the presence of
myogenin in the nucleus and GFP in the cytoplasm of the same cells (Figure
41).
To more accurately reflect the endogenous expression of myogenin that
is observed in wild-type differentiating myoblasts, I attempted to determine the
concentration of Dox required to induced Myog expression to wild-type levels in
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Figure 38
Luciferase activity of selected single stable myoblast colonies. Subpopulations
of cells infected with the RetroX-Tet-On Advanced vector and a luciferase
reporter vector that is activated by the tetracycline-controlled transactivator
encoded by the RetroX-Tet-On Advanced vector displayed varying levels of
reporter activity. Clones exhibiting 20- to 50-fold induction were chosen to
continue making double-stable lines with.
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Figure 39
Doxycyclin induction of Myog expression in double-stable myoblasts.
Subpopulations of cells infected with the RetroX-Tet-On Advanced vector and
pRetroX-Tight-Pur-Myog vector displayed varying levels of Myog activation in
the presence of Doxycyclin. Clones exhibiting high Myog expression in the
presence of Dox and little to no Myog expression in the absence of Dox were
chosen for further experiments.
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Figure 40
GFP reporter expression in double-stable myoblasts in the presence and
absence of Dox. Double-stable myoblasts fluoresce green only in the presence
of Dox indicating the induction of myogenin.
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Figure 41
Expression of myogenin and GFP in the same cells in the presence of Dox.
Immunofluorescence indicates the nuclear expression of myogenin and the
cytoplasmic expression of GFP in the same cells only in the presence of Dox.
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double-stable myobalsts. To accomplish this, a primary culture of wild-type
embryonic myoblasts was required. However, numerous attempts to isolate and
establish a wild-type line were unsuccessful due to technical difficulties such as
bacterial or yeast contaminations, unsuccessful preplatings due to an
overabundance of fibroblasts, and unviable populations of myoblasts either
dying or not proliferating. In attempts to circumvent these issues, I determined
whether an established line of commercially available C2C12 myoblasts would
be an acceptable substitute. qRT-PCR was used to determine the Myog
transcript levels in C2C12 myoblasts compared to other control myogenic cell
lines (Figure 42). C2C12 myoblasts possessed fewer Myog transcripts than
either wild-type satellite cells (adult skeletal muscle stem cells) or Myog-deleted
satellite cells. Furthermore, they had little more Myog than Myog-null myoblasts.
I therefore concluded that C2C12 myoblasts were an unacceptable alternative
for wild-type myoblasts.
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Figure 42
Expression of Myog in various populations of skeletal muscle stem cells. Myog
expression levels in C2C12 myoblasts are similar to that of Myog-deleted
satellite cells or Myog-null myoblasts and are far less than that of wild-type
satellite cells.
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Future Directions
To proceed with this project, several control experiments are necessary.
The concentration of Dox required to recapitulate endogenous wild-type
myogenin levels must be determined. In addition, the expression patterns of
genes previously determined to be either embryonic-specific [47] or adultspecific [13] must be determined in the presence of myogenin to demonstrate
that they recapitulate the gene activity patterns observed in the wild-type
scenario. If these experiments are successfully completed, this system will
provide a unique opportunity to identify the associated cofactors and chromatin
marks in the presence and absence of myogenin using chromatin
immunoprecipitation and MALDI-TOF mass spectrometry. With these
approaches, we can begin elucidating the mechanisms conferring myogenin’s
selective target gene activation.
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MATERIALS AND METHODS
Generation of Myog-deleted Mice
Mice used for this research were homozygous for the Myogflox allele and
harbored the CAGGCre-ER transgene [29, 111]. These animals consisted of a
C57BL/6 and 129 mixed background. Efficient deletion of Myog genomic DNA
in ~10 week old mice was achieved by a single injection of tamoxifen dissolved
in corn oil at a concentration of 10mg/40g body weight. All experimental
procedures described below followed the U.S. Public Health Service Policy on
Human Care and Use of Laboratory Animals and were approved by the
Institutional Animal Care and Use Committee at the The University of Texas
M.D. Anderson Cancer Center. In chapter 1, wild-type mice are defined as
tamoxifen-injected Myogflox/flox animals not harboring the Cre-recombinase gene.
In chapter 2, wild-type mice are defined as tamoxifen-injected mdx:Myogflox/flox
animals not harboring the Cre-recombinase gene.

Maximal Exercise Capacity
Involuntary Treadmill Running: Treadmill exercise regimes we derived
from previously published protocols [112]. Adult wild-type and Myog-deleted
mice were run on a rodent treadmill (Columbus Instruments Animal Treadmill:
Exer 3/6). This treadmill is equipped with a rear electrical stimulus grid set to
deliver 0.2 mA, an uncomfortable but not physically harmful shock. Mice were
determined to have reached the point of exhaustion when they made contact
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with the grid for a period of 10 seconds. The stimulus was then shut off in the
lane of the exhausted mouse.
The low-intensity exercise regime consisted of mice warming up for a
period of 30 minutes at 10 m/min (0° incline). The speed was then increased to
20m/min (0° incline), and mice were allowed to run to exhaustion. Exercise
duration and distance were recorded at exhaustion.
The high-intensity exercise regime consisted of mice warming up for a
period of 10 minutes at 10m/min on a 10° incline. The speed was then
increased by 2 m/min every 2 minutes while maintaining a 10° incline until
exhaustion. Exercise duration, distance, and maximum speed were recorded at
exhaustion.
Voluntary Wheel Running: Cages containing exercise wheels were built
in-house. Exercise wheels were suspended in the center of the cage and held in
place by wires fastened to the cage top and base. One mouse was housed in
each cage. Running wheels were connected to sensors recording time, average
speed, maximum speed, and distance ran since the last reset.

Assay for Blood Glucose and Blood Lactate
Blood glucose concentration was determined by using a Precision Xtra
glucometer (Abbott) at rest and within 30 seconds of reaching exhaustion.
Blood lactate concentration was determined by using a Lactate Pro blood lactate
test meter (Arkray) at rest and within 30 seconds of reaching exhaustion.
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Histological Assays
Hind-limb muscles were dissected and snap frozen in LN2-cooled
isopentane. Ten to 12 μm fresh-frozen sections were then cut on a Cryostat.
Fiber Typing ATP Staining Protocol: A protocol from Washington
University’s Neuromuscular Disease Center
(http://neuromuscular.wustl.edu/pathol/histol/atp.htm) was utilized to perform this
assay. Sections were incubated for 5 min in pre-incubation solution pH 4.6 (5.0
mL Barbital Acetate Solution [1.47 g sodium barbital, 0.97 g sodium acetate, 50
mL final volume in H2O], 10 mL 0.1N HCl, 4.0 mL H2O), rinsed with H2O, and
then incubated for 25 min in ATP solution H 9.4 (60 mg ATP powder, 6.0 mL of
0.1 M sodium barbital, 21.0 mL of H2O, 3.0 mL of 0.18 M Calcium Chloride).
Sections were washed with 3 exchanges of 1% calcium chloride for 10 min total,
2% cobalt chloride for 10 min, and 4 exchanges of 1:20 solution of 0.1M sodium
barbital, 5 exchanges of H2O. Sections were then exposed to 2% ammonium
sulfide for 20-30 seconds, washed with 5 exchanges of H2O, dehydrated in
ascending alcohols, cleared with xylene, and mounted with canada balsam.
Succinate Dehydrogenase Enzyme Stain: A modified protocol [113] from
the Universty of Nottingham Medical School was utilized for this assay
(http://www.nottingham.ac.uk/pathology/protocols/sdh.html). Sections were
incubated for 5 minutes in medium containing 0.2 mL of 500 mM sodium
succinate, 0.7 mg phenazine methosulphate, and 2.0 mL NBT Solution (6.5 mg
KCN, 185 mg EDTA, 100 mg Nitroblue tetrazolium, 100 mL 100mM phosphate
buffer pH 7.6 {12 mL of Solution A [1.36g KH2PO4 in 100mL H20] and 88 mL of
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Solution B [1.42g Na2HPO4/100mL H2O]}). Sections were then washed, fixed for
15 minutes in formaline, dehydrated in ascending alcohols, cleared with xylene,
and mounted.
Glycogen Stain: The Periodic Acid-Schiff Staining System from SigmaAldrich was utilized for this assay. Sections were hydrated with deionized water,
fixed with 10% neutral buffered formalin for 30 minutes, and then incubated in
Periodic Acid Solution for 5 minutes at room temperature. Sections were then
rinsed in distilled water and incubated in Schiff’s Reagent for 15 minutes at room
temperature. Slides were then washed in running tap water for 5 minutes and
counterstained in Hematoxylin Solution for 90 seconds. Slides were again
washed in running tap water, dehydrated in ascending alcohols, clear with 2
exchanges of Xylene, and mounted.
Fibrosis stain for Collagen and Elastin: Muscle sections were hydrated
with deionized water and then fixed for 30 minutes in neutral buffered formalin.
Slides were then incubated in Working Elastic Stain Solution for 10 minutes (20
mL Hematoxylin Solution, 3 mL Ferric Cholride Solution, 8mL Weigert’s Iodine
Solution, 5 mL Deionized water). Slides were then washed in deionized water
and incubated in Wokring Ferric Chloride Solution for 1 minute (3mL Ferric
Chloride Solution, 37 mL deionized water). Sections were then washed in tap
water followed by rinsing in 95% alcohol. Slides were then rinsed in deionized
water, incubated in Van Gieson Solution for 5 minutes, rinsed in 95% alcohol,
dehydrated in ascending alcohols, cleared with 2 exchanges of Xylene, and
mounted.
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Affymetrix Gene Microarray Hybridization and Analysis
Hindlimb muscles of trained wild-type and Myog-deleted mice were treated with
Trizol and used to isolate RNA from. Methods for this assay have been
described previously [13]. Hybridization probes were prepared from 100 ng of
total RNA from each sample. Three samples from each group tested were then
utilized in standard Affymetrix protocols to yield biotin labeled cRNA fragments
hybridized to Mouse Genome 430 2.0 GeneChips (Affymetrix, Santa Clara, CA).
Affymetrix GCOS software with Robust Multi-chip Averaging normalization was
employed to scan hybridized genechips [114]. For statistical analysis, two-tailed
pooled t-tests were conducted with the minimum significance value set to
P<0.05. Genes exhibiting expression changes greater than 1.4 fold were
retained for additional experimentation. The microarray data discussed in this
dissertation are MIAME compliant have been deposited in NCBI's Gene
Expression Omnibus [115] and are accessible through GEO Series accession
number GSE22046,
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22046).

RNA Isolation and qRT-PCR
RNA was isolated from hind-limb skeletal muscle of trained mice using
the Qiagen RNeasy Plus kit protocol. Reverse transcription was performed as
previously described [47]. TaqMan Gene Expression Assays (Applied
Biosystems) were utilized to determine cDNA abundance for each gene
assayed.
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Enzymatic Analysis
Enzymatic analysis was performed on Soleus, Extensor Digitorum
Longus (EDL), and Plantaris muscles from wild-type and Myog-deleted mice.
An abbreviated protocol includes the following steps: fast- and slow-twitch
muscles were isolated and snap frozen in LN2. Muscle was homogenized in
stabilizing medium at a 1:100 dilution based on wet weight. Stabilizing medium
consists of 50% glycerol, 20 mM phosphate buffer, pH 7.4, 5 mM betamercaptoethanol, 0.5 mM EDTA, 0.02% BSA [28].
Assays performed include: Pyruvate Kinase (PK, EC 2.7.1.40),
Hexokinase (HK, EC 2.7.1.1), Lactic Dehydrogenase (LDH, EC 1.1.1.27),
Glycerophosphate Dehydrogenase (GOPDH, EC 1.1.1.8), Glycogen
Phosphorylase (PHRL, EC 2.4.1.1), Fructose-6-Phosphate Kinase (PFK, EC
2.7.1.11), Adenylate Kinase (AK, EC 2.7.4.3), β-Hydroxybutyrate
Dehydrogenase (BDH, EC 1.1.1.30), Carnitine Acetyltransferase (CAT, EC
2.3.1.7), Pyruvate Carboxylase (PC, EC 6.4.1.1), Citrate Synthase (Cit-Syn, (EC
4.1.3.7), β-Hydroxyacyl-CoA Dehydrogenase (BOAC, EC 1.1.1.35), and Malic
Dehydrogenase (MDH, EC 1.1.1.37).
Cuvettes were prepared with the buffer and substrates required for the
particular assay and monitored with a spectrophotometer at A340nm until
constant. Diluted homogenates were then added to each cuvette in duplicate
and monitored with continuous spectrophotometric rate determination, recording
the change in A340nm for approximately 10 minutes at 25°C. The change in
A340nm/minute was determined using the maximum linear rate for both the test
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and the blank. Enzyme activities are given as mmol·kg-1·min-1. Detailed
protocol information is available from the Sigma Aldrich Enzyme Explorer Assay
Library (http://www.sigmaaldrich.com/life-science/metabolomics/enzymeexplorer.html).

Biochemical determination of glycogen content
Soleus and extensor digitorum longus (EDL) muscles were harvested
from wild-type, mdx, and mdx:Myog-deleted mice. An abbreviated protocol
followed from MBL International Corporation (www.mblintl.com) includes the
following steps: muscles were isolated and snap frozen in liquid nitrogen. Muscle
was homogenized in dH2O, boiled for 5 minutes, and centrifuged at 13,000rpm
for 5min. Glucoamylase hydrolysis enzyme mix was then added to the
supernatants. A master mix of development buffer, development enzyme mix,
and OxiRed probe were then added to the samples and left to incubate at room
temperature protected from light for 30 minutes. Samples were then measured
colorimetrically using a spectrophotometer at a wavelength of 570nm. Nonhydrolysis control readings were then subtracted from the experimental raw
values, and glycogen concentration was determined by applying the final values
to a standard curve.

Statistical Analysis
Statistical analyses were performed using 2-tailed pooled student’s t-tests
in Microsoft Excel 2008. A confidence level of p<0.05 was considered to be

140

statistically significant. Error bars represent one standard deviation from the
mean.
Increased Training Response: Thanks to the Department of Biostatistics for their
help in the statistical analysis of this data. A general linear model was fitted to
evaluate the effects of marker (wild-type vs. Myog-deleted), training status, and
their interaction on dependent variable distance. Analysis indicates that when
comparing to marker wild-type group, the difference in distance between the
training and non-training groups is significantly different.
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